Featured Chrome Extensions:

Casey IRACs are produced by an AI that analyzes the opinion’s content to construct its analysis. While we strive for accuracy, the output may not be flawless. For a complete and precise understanding, please refer to the linked opinions above.

Keywords

plaintiffdefendantdamagestestimonypiracy
plaintifftestimony

Related Cases

Gertner v. U.S., 76 Ct.Cl. 643, 1933 WL 1781
View Case »
Lopez v. Clifford Law Offices, P.C., 362 Ill.App.3d 969, 841 N.E.2d 465, 299 Ill.Dec. 53
View Case »
Garner v. Wolfinbarger, 430 F.2d 1093, 14 Fed.R.Serv.2d 490, Fed. Sec. L. Rep. P 92,759, Fed. Sec. L. Rep. P 92,819
View Case »
Horaist v. Doctor’s Hosp. of Opelousas, 255 F.3d 261
View Case »
Chevron Corp. v. Donziger, 974 F.Supp.2d 362, RICO Bus.Disp.Guide 12,464
View Case »
Justia Law Link
LexisNexis Link
Westlaw Link
CourtListener Link
Oyez Link

In re Polypropylene Carpet Antitrust Litigation, 93 F.Supp.2d 1348, 2000-2 Trade Cases P 72,981

Facts

The plaintiffs alleged that the defendants engaged in a conspiracy to fix and maintain the price of polypropylene carpet. To support their claims, they sought to introduce expert testimony from Dr. James T. McClave and Dr. David R. Kamerschen. Dr. Kamerschen analyzed market conditions to determine if they were consistent with collusive behavior, while Dr. McClave developed a regression model to estimate damages by forecasting competitive prices during the relevant period.

In support of these allegations, Plaintiffs seek to introduce the testimony of two experts, Dr. James T. McClave and Dr. David R. Kamerschen.

Issue

The main legal issue was whether the expert testimony of Dr. McClave and Dr. Kamerschen was admissible under the standards set forth in Daubert v. Merrell Dow Pharmaceuticals, Inc.

The main legal issue was whether the expert testimony of Dr. McClave and Dr. Kamerschen was admissible under the standards set forth in Daubert v. Merrell Dow Pharmaceuticals, Inc.

Rule

The court applied Federal Rule of Evidence 702, which allows expert testimony if the witness is qualified, the testimony is reliable, and it assists the trier of fact in understanding the evidence or determining a fact in issue.

The court applied Federal Rule of Evidence 702, which allows expert testimony if the witness is qualified, the testimony is reliable, and it assists the trier of fact in understanding the evidence or determining a fact in issue.

Analysis

The court found that both experts were qualified and that their methodologies were reliable. Dr. Kamerschen's analysis of market structure and behavior was deemed appropriate for assessing the potential for price-fixing, while Dr. McClave's regression model was accepted as a valid method for estimating damages. The court emphasized the importance of ensuring that expert testimony is relevant and reliable, allowing the jury to consider the evidence presented.

The court found that both experts were qualified and that their methodologies were reliable.

Conclusion

The court concluded that much of Dr. Kamerschen's testimony and all of Dr. McClave's testimony were admissible, allowing the plaintiffs to present their case regarding the alleged price-fixing conspiracy.

The court concluded that much of Dr. Kamerschen's testimony and all of Dr. McClave's testimony were admissible.

Who won?

The plaintiffs prevailed in part, as the court allowed their expert testimony to be admitted, which was crucial for their case against the defendants.

The plaintiffs prevailed in part, as the court allowed their expert testimony to be admitted.

You must be